Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction
about
Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientistsDeveloping therapies for heart failure with preserved ejection fraction: current state and future directionsPhenotypic spectrum of heart failure with preserved ejection fraction.Marked elevation of B-type natriuretic peptide in patients with heart failure and preserved ejection fractionPrevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction.Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fractionDiagnosis and management of heart failure with preserved ejection fraction: 10 key lessonsMetabolomic fingerprint of heart failure with preserved ejection fraction.Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction.Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation.Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study)Association of the frontal QRS-T angle with adverse cardiac remodeling, impaired left and right ventricular function, and worse outcomes in heart failure with preserved ejection fraction.Heart failure with preserved ejection fraction: a clinical dilemma.Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study.Heart failure with preserved ejection fraction: uncertainties and dilemmas.Designing Future Clinical Trials in Heart Failure With Preserved Ejection Fraction: Lessons From TOPCAT.Targets for Heart Failure With Preserved Ejection Fraction.How to Develop and Implement a Specialized Heart Failure with Preserved Ejection Fraction Clinical Program.Invasive Hemodynamic Assessment of Patients with Heart Failure and Pulmonary Hypertension.Resetting the neurohormonal balance in heart failure (HF): the relevance of the natriuretic peptide (NP) system to the clinical management of patients with HFPulmonary Hypertension in Heart Failure Patients: Pathophysiology and Prognostic Implications.Cardiac structural remodeling in hypertensive cardiomyopathy.Pulmonary Hypertension Is Associated With a Higher Risk of Heart Failure Hospitalization and Mortality in Patients With Chronic Kidney Disease: The Jackson Heart Study.Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.Skeletal Muscle Mitochondrial Content, Oxidative Capacity, and Mfn2 Expression Are Reduced in Older Patients With Heart Failure and Preserved Ejection Fraction and Are Related to Exercise Intolerance.Precision Medicine for Heart Failure with Preserved Ejection Fraction: An Overview.Einstein, the Blind Men, and the Elephant: Making Sense of Heart Failure With Preserved Ejection Fraction.Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus.Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction.Effect of Spironolactone on Exercise Tolerance and Arterial Function in Older Adults with Heart Failure with Preserved Ejection Fraction.Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction.Heart Failure With Preserved Ejection Fraction: A Perioperative Review.From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress.
P2860
Q26749044-9C383A05-9C84-4EDA-80AA-9D545C585E07Q33639223-DB110615-1308-42D5-B38A-5E81A4F90238Q33827302-D85C2A6F-6DBC-403A-830F-F5D6DEECF97CQ33917736-7E01735B-C726-4EF8-8BFA-4661654BDB0EQ34354197-FDECB640-F317-462C-9E81-EAC4342E8E34Q34803690-17020B05-FEDF-4D03-A05B-4300ECC4BB37Q35139959-6C70C649-CF68-4320-8AAF-118C9AA15081Q35641415-31FE4FD7-A921-4B30-B344-F5DBD03F63B7Q36266675-628FB3F5-EAA7-48F2-A133-F252C1701E97Q36289226-4B337F00-6DDD-400C-8906-C0FF91F31A80Q36463883-EB80D54F-5448-430D-8250-7AB60878A037Q36676033-40F3240A-F5C9-4E25-A003-952F8B3A325DQ36985609-36D10E3E-35F2-4B7F-8FC4-6C530CE54457Q37413536-B1BA53C1-FF22-420E-9B64-49703598D4E6Q38195149-B6337744-D441-4FE8-B0AE-CD9A57F76502Q38382930-65187800-E651-4139-B97F-D33909ED3306Q38529003-71CE8528-786A-4250-BA6B-C227522F0EE8Q38667037-2C5F3CA6-A1A8-4B97-B504-751E588728BDQ38688194-97C7C294-879B-41A5-AA0F-04422E4E1036Q38802217-8ED19B14-9FEA-4819-8CD1-58C9E4B03F93Q38807757-6155D46E-4C65-4498-816D-A0EDC4C65530Q38854043-B5C33946-5714-4234-A63D-19B6DB75F19BQ39011756-6E6B3B18-B2CC-46EC-842D-CE084020BFB9Q39076612-8B00B825-AE75-495F-BE4D-56D348D08ACAQ40161365-9C37BAEA-9B6D-4ACD-8C8B-16E9853CF5E4Q40256097-29228897-8A91-48A2-B66F-477DBD7795A9Q42062803-41A915F2-412C-4F54-A9D7-CC12B2CAD667Q45947184-78C820C5-F760-4352-8497-5CE591EAE8DDQ46630081-AAAFC65D-8D76-4D06-86BE-5A3DA71410C8Q47098884-3AA08CE4-31ED-4686-B01E-A54ADF300570Q47726582-00AC4042-1407-4F02-BB4D-990B53B0DC68Q47753168-C4F118F7-14F4-451E-AFB5-7E2E55D816D9Q47854367-1CE04054-7ECC-49D4-AC8D-BD77BAEC8A59Q50226285-BE8519E4-D634-4EE1-85E0-53721BE425F8Q53241855-85C10E51-75DC-4BCB-8C3B-98D0AD351E28
P2860
Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prevalence, clinical phenotype ...... th preserved ejection fraction
@ast
Prevalence, clinical phenotype ...... th preserved ejection fraction
@en
type
label
Prevalence, clinical phenotype ...... th preserved ejection fraction
@ast
Prevalence, clinical phenotype ...... th preserved ejection fraction
@en
prefLabel
Prevalence, clinical phenotype ...... th preserved ejection fraction
@ast
Prevalence, clinical phenotype ...... th preserved ejection fraction
@en
P2093
P2860
P1476
Prevalence, clinical phenotype ...... th preserved ejection fraction
@en
P2093
Michael A Burke
Nausheen Akhter
Sanjiv J Shah
Timothy M Loftus
Venkatesh Y Anjan
P2860
P304
P356
10.1016/J.AMJCARD.2012.05.014
P407
P577
2012-06-07T00:00:00Z